Home › AstraZeneca reverses $285m charge
 

Keywords :   


AstraZeneca reverses $285m charge

2013-09-04 13:06:45| Biotech - Topix.net

AstraZeneca has reversed a previous pre-tax impairment charge of $285 million after launching a final-stage Phase III clinical trial for the experimental drug olaparib in ovarian cancer.

Tags: charge reverses astrazeneca 285m

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.11Atlantic Tropical Weather Outlook
06.11Tropical Storm Rafael Graphics
06.11Tropical Storm Rafael Public Advisory Number 9A
06.11Summary for Tropical Storm Rafael (AT3/AL182024)
06.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 9
05.11Tropical Storm Rafael Wind Speed Probabilities Number 9
More »